7-87934542-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001324418.2(ADAM22):c.77G>T(p.Gly26Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,607,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001324418.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM22 | NM_001324418.2 | c.77G>T | p.Gly26Val | missense_variant | 1/32 | ENST00000413139.2 | NP_001311347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM22 | ENST00000413139.2 | c.77G>T | p.Gly26Val | missense_variant | 1/32 | 5 | NM_001324418.2 | ENSP00000412085.2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152216Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000297 AC: 7AN: 235400Hom.: 0 AF XY: 0.0000387 AC XY: 5AN XY: 129062
GnomAD4 exome AF: 0.0000536 AC: 78AN: 1455416Hom.: 0 Cov.: 31 AF XY: 0.0000525 AC XY: 38AN XY: 724062
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152216Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74348
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.77G>T (p.G26V) alteration is located in exon 1 (coding exon 1) of the ADAM22 gene. This alteration results from a G to T substitution at nucleotide position 77, causing the glycine (G) at amino acid position 26 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at